Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1

Interventions

Etoposide 6Ifosfamide 5Vincristine 4Radiotherapy 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Doxorubicin 4Cyclophosphamide 4Topotecan 2trioctyl phosphine oxide 1indolepropanol phosphate 1imetelstat 1etoposide phosphate 1Vinorelbine 1Vinblastine 1Trabectedin 1Thrombopoietin 1Radiosurgery 1Radiation 1Polymerase Chain Reaction 1Neoadjuvant Therapy 1Microarray Analysis 1Mesna 1MLN 8237 1Irinotecan 1Immunohistochemistry 1Glutamine 1Gene Expression Profiling 1GRN163L peptide 1Electroacupuncture 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neuroectodermal Tumors, Primitive, Peripheral × trioctyl phosphine oxide × Clear all
NCT00618813 2014-09-25

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

Children's Oncology Group

Phase NA Completed
35 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡